Title : Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression.

Pub. Date : 2019 Mar 1

PMID : 30684529






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression. beta-thujaplicin dual specificity phosphatase 6 Homo sapiens
2 Hinokitiol rapidly induced ERK phosphorylation followed by a sustained dephosphorylation, which accompanied with an increase in expression of tumor suppressor MKP-3 (mitogen-activated protein kinase phosphatase-3). beta-thujaplicin dual specificity phosphatase 6 Homo sapiens
3 Hinokitiol rapidly induced ERK phosphorylation followed by a sustained dephosphorylation, which accompanied with an increase in expression of tumor suppressor MKP-3 (mitogen-activated protein kinase phosphatase-3). beta-thujaplicin dual specificity phosphatase 6 Homo sapiens
4 Inhibition of hinokitiol-induced ERK activation by MEK inhibitor U0126 completely blocked expression of MKP-3. beta-thujaplicin dual specificity phosphatase 6 Homo sapiens
5 More importantly, inhibition of MKP-3 activity by NSC 95397 significantly inhibited hinokitiol-induced ERK dephosphorylation, ubiquitination and downregulation of survivin. beta-thujaplicin dual specificity phosphatase 6 Homo sapiens
6 These results suggested that hinokitiol inhibited growth of B16-F10 melanoma through downregulation of survivin by activating ERK/MKP-3/proteosome pathway. beta-thujaplicin dual specificity phosphatase 6 Homo sapiens